A R life Sciences Unit-1

Home / Infrastructure /  A R life Sciences Unit-1

A R Life Science Private Limited is conveniently located at Jeedimetla, Hyderabad. It is operational since 2007 and has a wide range of in-house APIs and intermediates production where innovation meets excellence with a focus on quality and precision. It is designed for large scale manufacturing of Intermediates. Making innovation and new experiments, we regularly invest in building capacities to develop cost-effective processes with no compromise on quality for efficient and affordable processes. We follow a standard operating procedure which corresponds to ICH guidelines.

Our infrastructure unit 1 is certified under USFDA, PMDA and ISO 9001-2015 and consists of:

Current Capacity

   Plant area 5989.30 SQM/ 1.5 acres 

   Production blocks – 02 

    Complete Onsite QA, QC and RA support 

  Manufacturing capacity of 66,000 L with reactors ranging from 1000 L to 5000 L 

   Total Reactors – 28 

  SSR – 19 

  GLR – 09 

  Autoclave – 02 

A R life Sciences Unit-1 : List of equipment

S.No Machinery Capacity No
1
SS316 Reactors
0.6KL - 3KL
17
2
MSGL Reactors
0.63KL - 3KL
6
3
Gas induction Reactors
1KL - 2KL
2
4
Total Reactor volume
47KL
5
Total GLR Volume
12KL
6
Total SSR Volume
35KL
7
Centrifuges
Available
8
Leaf filters
Air tray driers
9
Air tray driers
Available
10
Vacumm tray driers
Available
11
RCVD
Available
12
HPLC
Available
13
GC
Available
14
IR Spectrometer
Available
15
KF Titrator
Available
16
Melting range apparatus
Available
17
UV chamber
Available
18
pH meter
Available
19
Ovens
Available
20
Muffle furnace
Available
21
Weighing balances
Available

A R life Sciences Unit-1 - List of Utilities

S.No Utilities Capacity
1
Coal Fired Boiler
2TPH
2
Cooling Towers
600TR
3
Brine Compressor @ -20 Deg.C
52TR
4
Genset
500KVA
5
Vacuum (Water jet & steam jet)
1torr to 60Torr

Our Work Gallery

Photo Gallery

Maintaining a prominent position in the pharmaceutical manufacturing landscape with
ever-changing & evolving requirements on quality production, infrastructure, systematic labs, robust technologies and skilled scientists.